ClinicalTrials.Veeva

Menu

The Effect of Standard Cognitive-behavioral Therapy+Transcranial Alternating Current on Refractory Insomnia Disorder

Capital Medical University logo

Capital Medical University

Status

Enrolling

Conditions

Insomnia

Treatments

Other: CBTI + Sham tACS
Other: CBTI + tACS

Study type

Interventional

Funder types

Other

Identifiers

NCT06969040
CBTI+tACS for TRI

Details and patient eligibility

About

The main purpose of this study is to investigate the efficacy of CBTI + transcranial alternating current (TAC) technology in the treatment of refractory insomnia and the mechanism of 'cognitive-behavioural-brain network' interactions.

Full description

Difficult to treat insomnia is a sleep disorder that significantly reduces the quality of sleep for patients, seriously affecting their daily work and study. At present, the main treatment method for refractory insomnia in clinical practice is drug therapy. The problems with drug therapy mainly include easy recurrence after discontinuation and the need for long-term or even lifelong medication. However, tolerance or other adverse reactions limit its long-term use. In recent years, studies have shown that cognitive-behavioral therapy and transcranial alternating current stimulation are effective in treating chronic insomnia, prolonging sleep time and improving sleep quality. However, there have been no reports on the efficacy and safety of CBTI combined with tACS in the treatment of refractory insomnia. Based on the important role of tACS in regulating cortical excitability and spontaneous EEG activity, as well as the precise efficacy of CBTI in improving insomnia, we plan to use CBTI combined with tACS to treat refractory insomnia disorders, in order to improve the effectiveness of treatment. This study adopts a randomized double-blind controlled trial to investigate the efficacy and safety of CBT+tACS in the treatment of refractory insomnia, aiming to provide a basis for clinical data of CBT+tACS in the treatment of refractory insomnia.

Enrollment

70 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Meets the diagnostic criteria for insomnia in DSM-5;
  2. Pittsburgh Sleep Quality Index (PSQI) total score>5 points;
  3. Age ≥ 18 years old, with a junior high school education or above;
  4. Voluntarily participate in this study and sign an informed consent form.

Exclusion criteria

  1. Individuals with severe physical or mental illnesses are at risk of suicide;
  2. Clinically diagnosed or suspected sleep breathing disorders, restless leg syndrome, and sleep wake rhythm disorders, as well as workers on rotating shifts;
  3. Pregnant and lactating women;
  4. Currently undergoing any psychological therapy.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

70 participants in 2 patient groups

CBTI+tACS
Experimental group
Treatment:
Other: CBTI + tACS
CBTI + Sham tACS
Sham Comparator group
Treatment:
Other: CBTI + Sham tACS

Trial contacts and locations

1

Loading...

Central trial contact

Hongxing Wang, MD & PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems